Fri, 30 Oct 2026
07:01:04 am
Rudransh Sangwan
Published at: October 30, 2026, 3:42 AM
Synopsis
Galan Lithium targets first lithium chloride sales in Q4 2026, with Phase 1 capacity expansion planned and A$25 million in cash.

Galan Lithium expects its first lithium chloride concentrate sales from the Hombre Muerto West project in Argentina during Q4 CY2026. The company also reported progress on production ramp-up and expansion plans.
Galan's nanofiltration plant achieved at least 98% sulphate rejection, supporting its target of producing concentrate with 6% lithium content.
The company aims to reach 4,000 tonnes per annum (ktpa) of lithium carbonate equivalent (LCE) in the first half of 2027. Expansion work has begun to increase Phase 1 capacity to 5,200 tonnes per annum by the second half of 2027.
As of September 30, 2026, Galan reported A$25 million in cash and no debt drawn. It also has an undrawn US$6 million offtake prepayment facility.
Funds are being used for project ramp-up, expansion work and corporate costs.
Galan plans to conduct an airborne gravity survey at Greenbushes South, Western Australia, in November 2026. Results are expected in the first quarter of 2027 and will help identify potential lithium exploration targets.
Investors will monitor whether Galan achieves its first sales target in Q4 and meets its production expansion milestones in 2027.
Galan Lithium expects its first lithium chloride concentrate sales in Q4 2026 from its Hombre Muerto West project in Argentina.
Hombre Muerto West is Galan Lithium’s lithium development project in Argentina. The company is advancing production and expansion plans to supply lithium chloride concentrate and increase its lithium production capacity.
Galan Lithium aims to reach 4,000 tonnes per annum of lithium carbonate equivalent (LCE) in the first half of 2027. It is also working to increase Phase 1 capacity to 5,200 tonnes per annum in the second half of 2027.
Galan Lithium reported that its nanofiltration plant achieved at least 98% sulphate rejection. This supports the company’s objective of producing lithium chloride concentrate with a target lithium content of 6%.
Galan Lithium is expanding Phase 1 capacity to 5,200 tonnes per annum, with the target of achieving this level in the second half of 2027. The company also aims to reach 4,000 tonnes per annum of LCE in the first half of 2027.
As of September 30, 2026, Galan Lithium reported A$25 million in cash and no debt drawn. It also had access to an undrawn US$6 million offtake prepayment facility.
Galan Lithium plans to conduct an airborne gravity survey at Greenbushes South, Western Australia, in November 2026. Results are expected in the first quarter of 2027 and are intended to help identify potential lithium exploration targets.
Investors may monitor whether Galan achieves its Q4 2026 first-sales target, progresses towards its 2027 production goals and completes the Phase 1 expansion. Cash usage, project execution and exploration results will also be important indicators of progress.

Financial journalist specializing in market analysis, stock research, and investment trends. Dedicated to providing accurate, timely insights for informed decision-making.
Credentials: Experienced financial journalist with expertise in equity markets and economic analysis
The information provided in this article is for educational and informational purposes only and should not be construed as financial, investment, or legal advice. welomoney does not provide personalized investment recommendations.
For detailed terms and conditions, please read our Disclaimer and Terms of Service.

Motilal Oswal Q2 FY27 results show net profit rising 198% to ₹1,080 crore, revenue increasing 64% to ₹3,040 crore and EBITDA margin reaching 60.37%.

Bliss GVS Pharma Q2 FY27 results show revenue rising 37.3% to ₹261.13 crore, EBITDA jumping 161.4% and net profit increasing 196%.

Alivus Life Sciences Q2 FY27 results show net profit rising 51.3% to ₹196.8 crore, revenue growing 16% to ₹682 crore and EBITDA margin reaching 38.

Thyrocare Q2 FY27 revenue rose 25.1% to ₹270.81 crore, while net profit fell 66.9% to ₹15.89 crore amid a ₹44.98 crore impairment loss.

Patel Retail will invest ₹2 crore to add 20,000 sq ft to its Ambernath distribution centre, increasing covered area to 84,000 sq ft.